A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Seagen Inc.
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
EvolveImmune United, Inc
OncoC4, Inc.
Bayer
Memorial Sloan Kettering Cancer Center
Pfizer
IDEAYA Biosciences
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Rondo Therapeutics
Centre Oscar Lambret
City of Hope Medical Center
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Tasca Therapeutics
Pilatus Biosciences Inc
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Brigham and Women's Hospital
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Institut Bergonié
City of Hope Medical Center
Daiichi Sankyo
Boehringer Ingelheim
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Var2 Pharmaceuticals
Mayo Clinic
University of Pittsburgh
RenJi Hospital
University Health Network, Toronto
Cancer Research UK
NeoTX Therapeutics Ltd.
Tampere University Hospital
BicycleTx Limited